BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/12/2024 10:04:16 AM | Browse: 208 | Download: 745
 |
Received |
|
2023-10-15 11:41 |
 |
Peer-Review Started |
|
2023-10-15 11:42 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2023-11-22 22:44 |
 |
Revised |
|
2023-12-09 11:09 |
 |
Second Decision |
|
2024-01-09 02:52 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-01-09 04:09 |
 |
Articles in Press |
|
2024-01-09 04:09 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2024-01-16 22:55 |
 |
Typeset the Manuscript |
|
2024-02-19 03:24 |
 |
Publish the Manuscript Online |
|
2024-03-12 10:04 |
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Retrospective Cohort Study |
Article Title |
Combining systemic inflammatory response index and albumin fibrinogen ratio to predict early serious complications and prognosis after respectable gastric cancer
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Jing-Yao Ren, Da Wang, Li-Hui Zhu, Shuo Liu, Miao Yu and Hui Cai |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
8236110677 |
Central to guide local scientific and Technological Development |
ZYYDDFFZZJ-1 |
Natural Science Foundation of Gansu Province, China |
18JR2RA033 |
Gansu Da Vinci Robot High-End Diagnosis and Treatment Team Construction Project, National Key Research and Development Program |
2020RCXM076 |
|
Corresponding Author |
Hui Cai, Doctor, PhD, Chief Doctor, Dean, Doctor, Doctor, General Surgery Clinical Medical Center, Gansu Provincial Hospital, No. 204 Donggang West Road, Chengguan District, Lanzhou 730000, Gansu Province, China. caialonteam@163.com |
Key Words |
Inflammation; Albumin fibrinogen ratio; Gastric cancer; Complications; Prognosis |
Core Tip |
We conducted a retrospective analysis of the clinicopathological characteristics and relevant laboratory indices of 568 patients with gastric cancer. The aim of this study was to assess the clinical importance and prognostic significance of systemic inflammatory response index (SIRI) combining the albumin fibrinogen ratio (AFR) on early postoperative outcomes in patients with radical gastrectomy. The results demonstrated that the preoperative SIRI and AFR were significantly associated with five-year survival and the occurrence of major complications in gastric cancer patients. We created novel markers in the current study to aid in the early identification and therapy of gastric cancer. |
Publish Date |
2024-03-12 10:04 |
Citation |
Ren JY, Wang D, Zhu LH, Liu S, Yu M, Cai H. Combining systemic inflammatory response index and albumin fibrinogen ratio to predict early serious complications and prognosis after respectable gastric cancer. World J Gastrointest Oncol 2024; 16(3): 732-749 |
URL |
https://www.wjgnet.com/1948-5204/full/v16/i3/732.htm |
DOI |
https://dx.doi.org/10.4251/wjgo.v16.i3.732 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345